mAbxience is a global biopharmaceuticals expert that provides biopharmaceutical development, manufacturing, and supply. The company's CDMO services include process and analytical development, robust cGMP manufacturing, technology transfer expertise, batch and perfusion technology, and cell line development for mAbs, cytokines, chimeric proteins, recombinant hormones, adenoviral vaccines, and glycosylated recombinant proteins. Headquartered in Madrid, mAbxience has offices and manufacturing facilities in Spain, Switzerland, and Argentina.